Clinical trial · Observational
Serum Fetuin Level in Polycystic Ovary Syndrome
Serum Fetuin Level as a Marker in Polycystic Ovary Syndrome
NCT03819998CI-TRIAL-00039895unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
polycystic ovary syndrome is a common gynecological problem
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycystic Ovary | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| measurement of Fetuin-A level in serum | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- PCOS group
- description
- women who have PCOS
- interventionNames
- Diagnostic Test: measurement of Fetuin-A level in serum
- label
- control group
- description
- women who donnot have PCOS
- interventionNames
- Diagnostic Test: measurement of Fetuin-A level in serum
Primary outcomes (1)
- measure
- The number of women who will have high level of fetuin A and has PCOS
- timeFrame
- within a week
- description
- Evaluation of women who have PCOS in relation to fetuin A level
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 42 Years
Show eligibility criteria text
Inclusion Criteria: * women who have PCOS in group 1 and who donnot have PCOS in group 2 with age between 20 -42 years Exclusion Criteria: * women above 42 years old
References
Publications (0)
Data not yet available
No reference posted for this study.